This website is intended for ARIC investigators, researchers, participants, and the scientific community. The
website, is maintained for the ARIC participants, health professionals, and the general public.
The Atherosclerosis Risk in Communities Study (ARIC), sponsored by the
is a prospective epidemiologic study conducted in four U.S. communities. ARIC is designed to investigate the causes of atherosclerosis and its clinical outcomes, and variation in cardiovascular risk factors, medical care, and disease by race, gender, location, and date. To date, the ARIC project has published over 800 articles in peer-reviewed journals.
ARIC includes two parts: the
The Cohort Component began in 1987, and each
randomly selected and recruited a cohort sample of approximately 4,000 individuals aged 45-64 from a defined population in their community, to receive extensive examinations, including medical, social, and demographic data. Follow-up also occurs semi-annually, by telephone, to maintain contact and to assess health status of the cohort.
In the Community Surveillance Component, the four communities are investigated to determine the long term trends in hospitalized myocardial infarction (MI) and coronary heart disease (CHD) deaths in approximately 470,000 men and women aged 35-84 years.
Objectives of the Study
- Examine the ARIC cohort to characterize heart failure stages in the community, identify genetic and environmental factors leading to ventricular dysfunction and vascular stiffness, and assess longitudinal changes in pulmonary function and identify determinants of its decline.
- Cohort follow-up for cardiovascular events, including CHD, heart failure, stroke, and atrial fibrillation; and for the study of risk factors related to progression of subclinical to clinical CVD.
- Enhance the ARIC cohort study with cardiovascular outcomes research to assess quality and outcomes of medical care for heart failure and heart failure risk factors.
- Community surveillance to monitor long-term trends in hospitalized MI, CHD deaths, and heart failure (inpatient and outpatient).
- Provide a platform for ancillary studies, training for new investigators, and data sharing.